Could a new genetic approach make cancer therapies more effective? University of Michigan researchers are investigating how targeting the genes CDK12 and CDK13 can activate the STING signaling pathway, potentially boosting the body’s natural immune response and overcoming resistance to current treatments. Continue reading to learn more about this promising strategy.